ClinicalTrials.Veeva

Menu

Intermediate Vision in a Driving Simulator Environment: Comparison of the J&J EYHANCE With a Conventional Monofoc. IOL (JJ-EYHANCE)

A

Aalen University

Status

Completed

Conditions

Pseudophakia
Driving
Near Vision
Lenses, Intraocular

Treatments

Other: Posterior chamber intraocular lens (IOL)

Study type

Observational

Funder types

Other

Identifiers

NCT04059289
JJ-EY-AA_1

Details and patient eligibility

About

To compare (low contrast) visual acuity (VA) and contrast sensitivity (CS) - both at intermediate distances under nighttime driving conditions in a driving simulator between patients with bilateral EYHANCE IOLs OR bilateral conventional monofocal IOLs. Visual function testing in the driving simulator will be assessed without AND with (static) glare.

Additionally: Assessment of individual response times, scanpath characteristics, evaluation of test retest reliability and self-evaluation of (intermediate) vision and visual impairment related to glare.

Full description

To compare (low contrast) visual acuity (VA) and contrast sensitivity (CS) - both at intermediate distances under nighttime driving conditions in a driving simulator between patients with bilateral EYHANCE IOLs OR bilateral conventional monofocal IOLs. Visual function testing in the driving simulator will be assessed without AND with (static) glare.

Additionally: Assessment of individual response times, scanpath characteristics, evaluation of test retest reliability and self-evaluation of (intermediate) vision and visual impairment related to glare.

Simulator

Patients are instructed to drive with a constant speed of 40 km/h on a virtual parcours (straight lane). For testing of either (low contrast) visual acuity or contrast sensitivity, 8-position LANDOLT C's are presented at three locations (within the simulator car, AUDI A4, Ingolstadt/FRG):

(i) At the center of the instrument panel (distance 0.xx m) (ii) At the center of the navigation monitor (y.yy m) (iii) At the center of the rear monitor (z.zz m) A high resolution acoustic attention guidance for immediate gaze direction of the patients towards the three above-mentioned visual stimulus locations (i-iii) is mandatory.

Patients responses are recorded and response times can be extracted from the recordings.

Clinical ophthalmological-optical examinations

  • Medical/ophthalmological history

  • (Uncorrected and Best-corrected) visual acuity (RE,LE,BE) with remote and intermediate (66cm) 8 position LANDOLT C's.

  • LANG I stereotest (near distance)

  • Ocular alignment & ocular motility

  • Efferent & afferent pupillomotor status

  • Mesopic contrast sensitivity without/with glare (Optovist, VISTEC Inc./Olching/FRG)

  • Intraocular straylight perception (Q-Quant, OCULUS Inc, Wetzlar/FRG)

  • Slit lamp (anterior segment)

  • Ophthalmoscope (central fundus and fixation)

    • Primary objectives: log visual acuity (logVA) at preset low contrast level of 1:2.7 (logCS = 0.2) AND log contrast sensitivity (logCS) at a preset visual acuity level of 0.1 = 2/20)
    • Secondary objectives: test retest reliability (as operationalized by LOA = limits of agreement) AND response time (i.e. time interval between onset of stimulus presentation and final response) AND scanpath characteristics (fixation duration, fixation stability, annotation to regions of interest; saccade amplitude) self-evaluation (questionnaire, using visual analogue scales = VAS)

SHAPIRO WILK test (statistical testing for proving/disproving normal distribution) Descriptive statistics (either MEAN, standard deviation, in case of normally distributed data - else, MEDIAN, inter-quartile range (IQR).

Assessment of test/retest reliability: BLAND ALTMAN plots, limits of agreement (LOA) Between-group comparison: t-test (unpaired samples), in case of normally distributed data - else, WILCOXON signed-rank test

Enrollment

11 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent
  • S.p. (at least two months post surgery) bilateral uneventful IOL surgery (bilateral implantation of either EYHANCE IOL OR monofocal IOL)
  • Ophthalmological history normal, except cataract and uneventful IOL surgery
  • Distant visual high-contrast acuity > 20/25 in either eye
  • Normal stereopsis (all figures of the LANG I random dot stereo test correctly recognized)

Exclusion criteria

  • Age below 18 years
  • Chronic eye disease (except cataract)
  • History of ocular surgery (except complication-free IOL surgery)
  • Visual pathway lesions
  • Strabismus

Trial design

11 participants in 2 patient groups

Intraocular lens type I
Description:
Tecnis EYHANCE IOL (Johnson \& Johnson, New Brunswick/USA)
Treatment:
Other: Posterior chamber intraocular lens (IOL)
Intraocular lens type II
Description:
Clareon IOL (Alcon Pharma. Freiburg/FRG)
Treatment:
Other: Posterior chamber intraocular lens (IOL)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems